$CNAT Form 8-K

0
579
Biotech Stocks

Form 8-K for CONATUS PHARMACEUTICALS INC.


11-Mar-2015

Results of Operations and Financial Condition, Financial Statements

Item 2.02 Results of Operations and Financial Condition.On March 11, 2015, Conatus Pharmaceuticals Inc. issued a press release announcing its financial results for the quarter and full year ended December 31, 2014. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.


 

Item 9.01. Financial Statements and Exhibits.(d) Exhibits

Exhibit No. Description

99.1 Press release issued on March 11, 2015


LEAVE A REPLY

Please enter your comment!
Please enter your name here